DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 240,335 | $60,930,000 | 15.17% |
| Defender Capital, LLC. | 139,995 | $35,492,000 | 13.92% |
| Third Point | 2,300,000 | $583,096,000 | 13.80% |
| Riverstone Advisors, LLC | 62,491 | $15,843,000 | 9.95% |
| AGF Investments America Inc. | 95,401 | $24,186,000 | 9.52% |
| Eos Focused Equity Management, L.P. | 33,480 | $8,488,000 | 8.58% |
| R.P. Boggs & Co. | 22,145 | $5,614,000 | 7.38% |
| Front Street Capital Management, Inc. | 118,386 | $30,013,000 | 7.12% |
| CORTLAND ASSOCIATES INC/MO | 165,285 | $41,903,000 | 6.93% |
| Alphinity Investment Management Pty Ltd | 832,459 | $211,045,000 | 6.44% |
| Mirova US LLC | 1,152,491 | $292,179,000 | 6.29% |
| Intermede Investment Partners Ltd | 894,850 | $226,862,000 | 6.29% |
| AMS Capital Ltda | 44,655 | $11,321,000 | 5.98% |
| TRAN CAPITAL MANAGEMENT, L.P. | 205,299 | $52,047,000 | 5.95% |
| Alapocas Investment Partners, Inc. | 23,588 | $5,980,000 | 5.94% |
| Gouws Capital LLC | 24,347 | $6,172,000 | 5.86% |
| Lincoln Capital LLC | 82,096 | $20,813,000 | 5.85% |
| Cypress Capital, LLC | 151,273 | $38,351,000 | 5.58% |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 1,755,783 | $445,125,000 | 5.47% |
| Edgewood Management | 7,310,111 | $1,853,259,000 | 5.47% |
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists DANAHER CORPORATION's shareholders in Q2 2022. To view DANAHER CORPORATION's shareholder history, click here.